PITTSBURGH and NEW YORK, April 26, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE) today announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a ...

BASKING RIDGE, N.J., Oct. 26-- Dey Pharma, L.P., a subsidiary of Mylan Inc. (Nasdaq: MYL), today launched a newly designed, patient-friendly EpiPen® Auto-Injector 0.3/0.15 mg. This next-generation ...

CVS Health, which owns more than 9,600 retail pharmacies and 1,100 walk-in clinics, will offer a lower-cost generic version of the Adrenaclick epinephrine auto-injector, targeting Mylan after the ...

Mylan has signed a multi-year strategic alliance agreement with Walt Disney Parks and Resorts to help increase awareness of anaphylaxis, a life-threatening (severe) allergic reaction. The agreement ...

* Mylan says authorized generic, which will reach pharmacies starting next week, has same drug formulation and device functionality as Epipen auto-injector Sign up here. * Authorized generic for ...

Mylan (MYL) expects that its EpiPen Auto-Injector franchise, which currently accounts for 85% of the epinephrine injection market for the treatment of anaphylaxis, will continue to benefit from strong ...

WASHINGTON, April 17 (Reuters) - The U.S. Supreme Court on Monday declined to hear a bid by Sanofi SA to revive its antitrust lawsuit accusing rival pharmaceutical company Viatris Inc of illegally ...

Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "Epinephrine Auto-Injection Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Epinephrine ...

Mylan Specialty, the fully integrated specialty pharmaceutical business of Mylan Inc, announced new EpiPen4Schools programme offerings as part of the company's commitment to support the growing need ...

Anaphylaxis is a serious, potentially life-threatening allergic reaction that can affect several organ systems in the body and may threaten breathing and blood circulation. The most common causes of ...